Cervical cancers avoided by HPV immunisation

Abstract

In 2020, WHO launched a global strategy to accelerate the elimination of cervical cancer as a public health problem,1 one of the most common causes of cancer deaths in women globally. While recognising that the burden of disease is carried by low-income countries, WHO did not avoid setting challenging targets. Where there are no existing cancer control measures, WHO believes the priority should be human papillomavirus (HPV) immunisation of girls to prevent future cervical cancers and other HPV-related malignancies.